PCNA-associated factor P15PAF , targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients.
By: Chengjuan Jin, Zhaojian Liu, Yingwei Li, Hualei Bu, Yu Wang, Ying Xu, Chunping Qiu, Shi Yan, Cunzhong Yuan, Rongrong Li, Nannan Diao, Zhiwei Zhang, Xiangxiang Wang, Lidong Liu, Beihua Kong

Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhua Xi Road, Jinan, P.R. China, 250012.
2017-11-29; doi: 10.1002/ijc.31800
Abstract

Activation of the FOXM1 signaling pathway and the PI3K/AKT/mTOR signaling pathway is associated with poor prognosis in ovarian cancer. In this study, we demonstrated that P15PAF (KIAA0101) was significantly upregulated in high-grade serous ovarian cancer (HGSOC) and that high KIAA0101 expression was associated with poor prognosis. FOXM1transcriptionally activated KIAA0101 to drive proliferation and metastasis of ovarian cancer cells. KIAA0101 activated the PI3K/AKT/mTOR signaling pathway to inhibit cisplatin-induced apoptosis and autophagy in ovarian cancer cells resulting in cisplatin resistance. Thus, KIAA0101 was closely related to the FOXM1 and PI3K/AKT/mTOR signaling pathways. Collectively, these findings provide insights into the mechanisms of poor prognosis of ovarian cancer and have implications for the development of both predictive and therapeutic biomarkers for the treatment of ovarian cancer. This article is protected by copyright. All rights reserved.



This article is protected by copyright. All rights reserved.

PMID:30129654






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements